Total raised
$38.4M
Last: Undisclosed 2021-09
Stage
Acquired
Founded
2013
Headcount
22
HQ
Yavne
Sector
Health Tech & Life Sciences
About
BELKIN Laser is developing a contact-free laser procedure for the primary treatment of glaucoma. The device delivers a single laser beam, with a pulse duration of a few nanoseconds, 120 times in about a second to the limbus, enhancing intraocular fluid drainage and lowering intraocular pressure, a key risk factor for glaucoma. Suitable for use in clinics and hospitals, this technology serves as an initial or adjunctive treatment for glaucoma, including both open angle and angle closure types.
The company received FDA Clearance for the Eagle Device.
Funding history · 5 rounds · $38.4M total
2021-09
Undisclosed
Undisclosed
2020-07
Series B
$12.3M
2017-04
Series A
$2.5M
2015-07
Convertible Debt
$550K
2013-04
Seed
$600K
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary treatment developed by BELKIN Vision?
- BELKIN Vision developed a contact-free laser procedure for the primary treatment of glaucoma, utilizing a device called Eagle that delivers a single laser beam to enhance intraocular fluid drainage.
- When was BELKIN Vision acquired and by whom?
- BELKIN Vision was acquired by Alcon Pharmaceuticals in July 2024. The acquisition was closed due to this event, making the company inactive.
- What was the acquisition amount for BELKIN Vision?
- BELKIN Vision was acquired for an amount of $81,000,000 in July 2024.
- When did BELKIN Vision receive FDA Clearance for its Eagle Device?
- BELKIN Vision announced FDA Clearance for its Eagle Device in December 2023.
- When did BELKIN Vision's Eagle™ device receive CE Mark under MDR?
- BELKIN Vision's Eagle™ device received CE Mark under MDR in May 2022.
- What was the total amount raised by BELKIN Vision through funding rounds?
- BELKIN Vision raised a total of $38,440,000 through various funding rounds. For a full financing history, users can refer to startupim.
- Which investor led BELKIN Vision's Series B funding round?
- CR-CP Life Science Fund led BELKIN Vision's Series B funding round in July 2020.
- When did BELKIN Laser change its corporate name to BELKIN Vision?
- Belkin Laser announced its corporate name change to BELKIN Vision in June 2021.
- How many employees did BELKIN Vision have at the time of its acquisition?
- BELKIN Vision had 22 employees at the time of its acquisition.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
SensingLaser
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
ophthalmologyhospitalsnon-invasivemedical-deviceslasersglaucomapain-freepain-freehealthcare-providersclinicsmedical-technologieseye-diseasesdoctorsoptronicsautomationtreatmentseye-trackingalgorithms